Pesquisar
Oculis Holding AG
OCSAdicionar à lista de desejos
14.120USD
+0.590+4.36%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
876.03MValor de mercado
PerdaP/L TTM
Mais detalhes de Oculis Holding AG Empresa
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
Informações de Oculis Holding AG
Código da empresaOCS
Nome da EmpresaOculis Holding AG
Data de listagemMar 03, 2023
CEOSherif (Riad)
Número de funcionários49
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 03
EndereçoBahnhofstrasse 20
CidadeZUG
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSwitzerland
Código postal6300
Telefone41417113960
Sitehttps://oculis.com/
Código da empresaOCS
Data de listagemMar 03, 2023
CEOSherif (Riad)
Executivos da empresa Oculis Holding AG
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
288.43K
+6.80%
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
90.75K
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
77.32K
+6.80%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
6.53K
--
Dr. Riad Sherif, M.D.
Dr. Riad Sherif, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Anthony A. (Tony) Rosenberg
Mr. Anthony A. (Tony) Rosenberg
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Arshad M. Khanani, M.D.
Mr. Arshad M. Khanani, M.D.
Independent Director
Independent Director
--
--
Mr. Robert K. Warner
Mr. Robert K. Warner
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
288.43K
+6.80%
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
90.75K
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
77.32K
+6.80%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
6.53K
--
Perguntas frequentes
Quem são os cinco principais acionistas de Oculis Holding AG?
Os cinco principais acionistas de Oculis Holding AG são: Mr. Martijn Kleijwegt
Quantas instituições possuem ações da Oculis Holding AG (OCS)?
Em 2026Q1, 72 instituições possuíam ações da Oculis Holding AG, com valor de mercado aproximado de 27.88M, representando 54.68% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 2538023.00.